• LAST PRICE
    5.6300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    3.6300/ 5
  • Ask / Lots
    6.0000/ 2
  • Open / Previous Close
    0.0000 / 5.6300
  • Day Range
    ---
  • 52 Week Range
    Low 5.5900
    High 16.2500
  • Volume
    1,177
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 5.74
TimeVolumeHSDT
09:32 ET30355.59
09:50 ET3005.71
09:53 ET4005.7
10:02 ET87395.7
10:04 ET8005.7704
10:08 ET1005.67
10:15 ET2005.67
10:24 ET6605.6681
10:51 ET9005.71
12:26 ET1135.62
12:50 ET6275.61
01:20 ET2795.6379
02:14 ET1775.63
02:21 ET3805.63
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesHSDT
Helius Medical Technologies Inc
4.0M
0.0x
---
United StatesAEMD
Aethlon Medical Inc
4.6M
-0.3x
---
United StatesOHCS
Optimus Healthcare Services Inc
4.8M
-0.6x
---
United StatesBSGM
BioSig Technologies Inc
4.5M
-0.1x
---
United StatesMOTS
Motus GI Holdings Inc
1.1M
0.0x
---
United StatesDGEN
Deltagen Inc
40.0
0.0x
---
As of 2024-02-27

Company Information

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

Contact Information

Headquarters
642 Newtown Yardley RoadNEWTOWN, PA, United States 18940
Phone
215-944-6100
Fax
302-655-5049

Executives

Independent Chairman of the Board
Blane Walter
President, Chief Executive Officer, Director
Dane Andreeff
Chief Financial Officer, Treasurer, Company Secretary, Director
Jeffrey Mathiesen
Chief Medical Officer
Antonella Favit-Van Pelt
Independent Director
Paul Buckman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.0M
Revenue (TTM)
---
Shares Outstanding
708.3K
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.46
EPS
---
Book Value
$14.45
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.